The rising interest in GLP-1 drugs for metabolic conditions has led to a debate about delivery routes : skin-applied devices versus capsules. Usually , GLP-1 therapies were solely available in pill https://lucytimd137559.post-blogs.com/61795333/glp-1-transdermal-delivery-systems-vs-oral-medications-which-right-for-the-patient